Patterns of adjuvant therapy use and survival outcomes in patients with rectal cancer not receiving neoadjuvant therapy in an Australian cohort.
Kate Wilkinson(Liverpool Hospital), Daniel Brungs(University of Wollongong), Cheok Soon Lee(Liverpool Hospital), Weng Ng(Sir Run Run Shaw Hospital), Stephanie Lim(Camden and Campbelltown Hospitals), Sharlyn Kang, Wei Chua(Liverpool Hospital), Elias Nasser(Southwestern Medical Center), Ray Asghari(Bankstown Lidcombe Hospital), Sarah Maloney(Liverpool Hospital), James Chen(Stanford University), Hiren Mandaliya(Lake Macquarie Private Hospital)
Cited by 0
Related Papers
Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened
|Genes & Development|2002|1.5k
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)
|Translational Lung Cancer Research|2019|392